PulseSelect™ PFA System
Paroxysmal and Persistent Atrial Fibrillation
Key Facts
Indication
Paroxysmal and Persistent Atrial Fibrillation
Phase
Approved
Status
Commercial Launch
Company
About Medtronic
Medtronic is a pioneering medical technology company founded in 1949, best known for inventing the first wearable cardiac pacemaker. Its mission to 'alleviate pain, restore health, and extend life' is executed through a diversified portfolio of devices, therapies, and digital solutions across four core operating segments. The company's strategy combines deep clinical expertise, a people-centered approach, and strategic M&A to drive innovation in chronic disease management and personalized care.
View full company profileTherapeutic Areas
Other Paroxysmal and Persistent Atrial Fibrillation Drugs
| Drug | Company | Phase |
|---|---|---|
| Abelis PFA System | johnson-johnson-medtech | Pivotal Trial |